financetom
Business
financetom
/
Business
/
Mastercard Insider Sold Shares Worth $508,474, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mastercard Insider Sold Shares Worth $508,474, According to a Recent SEC Filing
Jun 23, 2025 1:56 PM

04:41 PM EDT, 06/23/2025 (MT Newswires) -- Raj Seshadri, Chief Commercial Payments Officer, on June 20, 2025, sold 949 shares in Mastercard ( MA ) for $508,474. Following the Form 4 filing with the SEC, Seshadri has control over a total of 14,021 Class A common shares of the company, with 14,021 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1141391/000114139125000116/xslF345X05/wk-form4_1750710663.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Canada to assess toxicity of compound found in oil sands tailings
Canada to assess toxicity of compound found in oil sands tailings
May 30, 2024
May 30 (Reuters) - Canada has agreed to assess whether naphthenic acids found in northern Alberta's oil sands tailings ponds should be classed as toxic under federal law, a move that could pave the way for stricter regulations, environmental group Ecojustice said on Thursday. Tailings - a mix of water, clay, sand and trace metals - are a byproduct of...
HP Stock Makes Historic Move Higher: What's Going On?
HP Stock Makes Historic Move Higher: What's Going On?
May 30, 2024
HP Inc. ( HPQ ) experienced a historic stock surge Thursday afternoon, with shares climbing as much as 19% — the largest one-day gain since 1999 — following the release of its second-quarter financial results. What Happened: HP shares jumped after the tech giant reported net revenue of $12.8 billion, above the consensus estimate of $12.6 billion. Adjusted EPS rose...
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar
May 30, 2024
03:46 PM EDT, 05/30/2024 (MT Newswires) -- Summit Therapeutics ( SMMT ) shares soared 137% in recent trading Thursday after the company shared results of ivonescimab meeting primary endpoint of progression-free survival to treat a type of lung cancer, beating Merck's ( MRK ) pembrolizumab. Results from the phase 3 trial showed that ivonescimab was statistically better at improving progression-free...
EXPLAINER-What to know about bird flu in dairy cows and the risk to humans
EXPLAINER-What to know about bird flu in dairy cows and the risk to humans
May 30, 2024
(Adds details on third human case in paragraph 1, 2; updates throughout) By Julie Steenhuysen CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found...
Copyright 2023-2026 - www.financetom.com All Rights Reserved